共 378 条
[1]
Harms KL(2016)Analysis of prognostic factors from 9387 Merkel Cell carcinoma cases forms the basis for the new 8th edition AJCC staging system Ann Surg Oncol 23 3564-3571
[2]
Healy MA(2017)Merkel cell carcinoma Nat Rev Dis Primers 3 17077-1385
[3]
Nghiem P(2016)Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial Lancet Oncol 17 1374-2552
[4]
Sober AJ(2016)PD-1 blockade with pembrolizumab in advanced Merkel-cell carcinoma N Engl J Med 374 2542-702
[5]
Johnson TM(2019)Durable tumor regression and overall survival in patients with advanced Merkel cell carcinoma receiving pembrolizumab as first-line therapy J Clin Oncol 37 693-e180077
[6]
Bichakjian CK(2018)Efficacy and safety of first-line avelumab treatment in patients with stage IV metastatic merkel cell carcinoma: a preplanned interim analysis of a clinical trial JAMA Oncol 4 e180077-1279
[7]
Wong SL(2019)Rescue therapy for patients with anti-PD-1-refractory Merkel cell carcinoma: a multicenter, retrospective case series J Immunother Cancer 7 170-1668
[8]
Becker JC(2017)Systematic literature review of efficacy, safety and tolerability outcomes of chemotherapy regimens in patients with metastatic Merkel cell carcinoma Future Oncol 13 1263-1100
[9]
Stang A(2019)Breaking avelumab resistance with combined ipilimumab and nivolumab in metastatic Merkel cell carcinoma? Ann Oncol 30 1667-5234
[10]
DeCaprio JA(2008)Clonal integration of a polyomavirus in human Merkel cell carcinoma Science 319 1096-3727